剂量计参数与局部控制在头癌终极放射治疗中的相关性
Mikiko Yamashita1,2, Shingo Ohira2,3, Hiroaki Tanabe4
1Department of Radiological Technology, Kobe City Medical Center General Hospital, Hyogo, Japan; m-yamashita@kcho.jp.
In vivo (Athens, Greece)
|February 28, 2024
概括
精确的辐射疗法剂量到瘤总体积 (GTV) 对于在头癌的局部控制至关重要. 精确的剂量评估,包括D99%和Dmin,有助于预测治疗反应,并确定需要在治疗规划中验证的领域.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 头癌的放射治疗 (RT) 结果通常根据阶段,患者因素和化疗进行评估.
- 对于H&N癌症的最终RT的局部控制受处方剂量对瘤总体积 (GTV) 和所使用的计算算法的影响.
研究的目的:
- 调查处方剂量对GTV和计算算法对H&N癌症最终RT局部控制的影响.
- 为了分析剂量评估参数,使用RT后的后续成像.
主要方法:
- 分析了154名H&N癌症患者,这些患者接受了体积调节弧线治疗.
- 根据随访图像,患者被分为响应者和非响应者.
- 剂量评估参数 (Dmax,D1%,D50%,D99%,Dmin) 与GTV在各组之间进行了比较.
主要成果:
- 给99%的GTV (D99%) 的剂量显示了局部失败和响应者之间以及局部失败和非响应者之间存在显著差异.
- 对GTV的最低剂量 (Dmin) 在响应者和不响应者之间,以及响应者和局部失效之间有显著差异.
结论:
- 检查所有治疗计划切片的剂量分配是必不可少的.
- 精确评估GTV剂量对于优化H&N癌症放射治疗中的局部控制至关重要.
相关概念视频
Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...


